T. Rowe Price Associates’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $65K | Buy |
+11,811
| New | +$65K | ﹤0.01% | 2967 |
|
2025
Q1 | – | Sell |
-361,890
| Closed | -$3.73M | – | 3069 |
|
2024
Q4 | $3.73M | Buy |
+361,890
| New | +$3.73M | ﹤0.01% | 1364 |
|
2023
Q1 | – | Sell |
-457,327
| Closed | -$1.97M | – | 2947 |
|
2022
Q4 | $1.97M | Sell |
457,327
-13,299
| -3% | -$57.2K | ﹤0.01% | 1467 |
|
2022
Q3 | $8.93M | Buy |
+470,626
| New | +$8.93M | ﹤0.01% | 1080 |
|